Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449042 · ClinicalTrials.gov registry record
The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry
A clinical trial of COVID-19 and Airway Management, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 14,835
- Enrollment target
- 1
- Study location
NCT04449042: Completed study of COVID-19 and Airway Management, sponsored by Boston Children's Hospital.
NCT04449042 is a study of COVID-19 and Airway Management that has completed, run by Boston Children's Hospital. The registered enrollment target is 14,835 participants, below the 38,415-participant average among 298 other COVID-19 trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04449042, a study of COVID-19 and Airway Management, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 14,835 participants
- Enrollment target
- 1
- Study location
Study Summary
The COVID-19 pandemic has disrupted anesthesia care all over the world. There remains very little data on current practice patterns and patient outcomes, particularly in anesthetized children. This is a prospective observational, multi-center study to investigate airway management related outcomes in children undergoing anesthesia during this pandemic. The investigators will compare the incidence of complications (particularly hypoxemia) in patients with COVID-19 to those who are COVID-19 negative during airway management. PAWS COVID-19 Registry https://is.gd/PEDICOVID19 Registration link https://is.gd/researchrequest
Primary Outcome
incidence of complications (particularly hypoxemia) in patients with COVID-19 to those who are COVID-19 negative during airway management
Conditions Studied
Interventions
- PROCEDURE airway management during sedation or general anesthesia
Study Locations (1)
Massachusetts
- Boston Children's Hopsital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,835 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-10-31 |
What the finished NCT04449042 record still lists
NCT04449042 is an observational study that tracks outcomes without assigning an intervention. Its 14,835 participants enrollment target places it among the larger protocols in the corpus, below the 38,415-participant average among 298 other COVID-19 trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which airway management during sedation or general anesthesia is the first listed.
NCT04449042 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04449042 about?
NCT04449042 is a clinical study titled "The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry". The COVID-19 pandemic has disrupted anesthesia care all over the world. There remains very little data on current practice patterns and patient outcomes, particularly in anesthetized children. This is a prospective observational, multi-center study to investigate airway management related outcomes i...
What is the current status of trial NCT04449042?
This trial is currently completed. The enrollment target is 14,835 participants. The study started on 2020-04-01. Estimated completion is 2020-10-31.
What conditions does trial NCT04449042 study?
This clinical trial studies the following conditions: COVID-19, Airway Management.
What interventions are being tested in trial NCT04449042?
The interventions under investigation include: airway management during sedation or general anesthesia (PROCEDURE).
Who is sponsoring clinical trial NCT04449042?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04449042 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04449042's enrollment target sits among peer trials
14,835 22nd of 298 higher than 277 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI